HLB Co., Ltd. HLB Co., Ltd.

HLB Co., Ltd.

028300

Classificação em ações #3914
HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and... HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and naval construction. In South Korea, its maritime division produces and distributes a diverse range of lifeboats, catering to offshore platforms, drilling vessels, and passenger cruise liners. Its offerings include traditional, free-fall, and rescue boat designs. Beyond lifeboats, HLB's product portfolio extends to marine and yacht engines, hooks, and a variety of specialized vessels such as rigid inflatable (RIB), patrol, fishing, aluminum, and leisure boats, as well as fishery inspection ships and general safety equipment. The company further offers comprehensive support services, including inspection and repair of lifeboats and davits, service engineering training, and the provision of spare parts. On the pharmaceutical front, HLB is engaged in the development of Riboseranib, a targeted anti-cancer agent, and Apilia, a treatment specifically for ovarian cancer. Established in 1975, HLB Co., Ltd. is headquartered in Ulsan, South Korea.
Preço da ação
$31.27
Valor de mercado
$4.16B
Variação (1 dia)
6.78%
Variação (1 ano)
1.26%
País
KR
Negociar HLB Co., Ltd. (028300)

Categoria

Healthcare
Histórico de preços das ações de HLB Co., Ltd. (028300)
Preço de fecho mais alto: $29.89 em 2026-10-01

Preço de fecho mais baixo: $1.36 em 2008-12-01
Histórico de preços das ações da HLB Co., Ltd. de 2008 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) 0.63%
2025 -33.96%
2024 57.41%
2023 40.26%
2022 -17.38%
2021 -30.97%
2020 8.36%
2019 23.72%
2018 110.61%
2017 199.59%
2016 -34.89%
2015 161.99%
2014 189.01%
2013 -5.55%
2012 30.30%
2011 0.39%
2010 -50.22%
2009 13.14%
2008 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$536.87 25.89%
US
$191.60 613.60%
US
$137.83 -3.78%
AU
$291.76 2.51%
BE
$884.30 8.61%
NL